Global Immunogenicity Testing Service Market Research Report 2024

Publication ID:

PB505248321

Publication Date:

May 30, 2024

Pages:

100

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

IT Services [2]

Computing & Electronics [3]

Description:

Immunogenicity testing service refers to a laboratory service that evaluates the immune response of an individual to a specific substance, such as a drug or vaccine. This testing is performed to determine the likelihood of an immune response, including the production of antibodies, against the substance being tested. Immunogenicity testing is often conducted during the development of new drugs or vaccines to assess their safety and effectiveness. It can also be used in clinical settings to monitor the immune response of patients receiving certain treatments. The results of immunogenicity testing can help guide treatment decisions and ensure patient safety.
The global Immunogenicity Testing Service market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Immunogenicity Testing Service is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Immunogenicity Testing Service is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Immunogenicity Testing Service in Enterprise is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Immunogenicity Testing Service include Profacgen, Charles River Laboratories, Pacific BioLabs, Celerion, Precision Medicine Group, BioAgilytix, FyoniBio, Chimera Biotec and Alcyomics, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Immunogenicity Testing Service, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Immunogenicity Testing Service.
Report Scope
The Immunogenicity Testing Service market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Immunogenicity Testing Service market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Immunogenicity Testing Service companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Profacgen
Charles River Laboratories
Pacific BioLabs
Celerion
Precision Medicine Group
BioAgilytix
FyoniBio
Chimera Biotec
Alcyomics
ProImmune
Creative Biolabs
SGS
Eurofins Scientific
Syrinx Bioanalytics
Pharmaron
NorthEast BioAnalytical Laboratories
Svar Life Science
CellCarta
BioGenes
EpiVax
ImmunXperts
Segment by Type
A Single Assay
Two Assays
Segment by Application
Enterprise
Factory
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Immunogenicity Testing Service companies鈥� competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Immunogenicity Testing Service Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 A Single Assay
1.2.3 Two Assays
1.3 Market by Application
1.3.1 Global Immunogenicity Testing Service Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Enterprise
1.3.3 Factory
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Immunogenicity Testing Service Market Perspective (2019-2030)
2.2 Immunogenicity Testing Service Growth Trends by Region
2.2.1 Global Immunogenicity Testing Service Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Immunogenicity Testing Service Historic Market Size by Region (2019-2024)
2.2.3 Immunogenicity Testing Service Forecasted Market Size by Region (2025-2030)
2.3 Immunogenicity Testing Service Market Dynamics
2.3.1 Immunogenicity Testing Service Industry Trends
2.3.2 Immunogenicity Testing Service Market Drivers
2.3.3 Immunogenicity Testing Service Market Challenges
2.3.4 Immunogenicity Testing Service Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Immunogenicity Testing Service Players by Revenue
3.1.1 Global Top Immunogenicity Testing Service Players by Revenue (2019-2024)
3.1.2 Global Immunogenicity Testing Service Revenue Market Share by Players (2019-2024)
3.2 Global Immunogenicity Testing Service Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Immunogenicity Testing Service Revenue
3.4 Global Immunogenicity Testing Service Market Concentration Ratio
3.4.1 Global Immunogenicity Testing Service Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Immunogenicity Testing Service Revenue in 2023
3.5 Immunogenicity Testing Service Key Players Head office and Area Served
3.6 Key Players Immunogenicity Testing Service Product Solution and Service
3.7 Date of Enter into Immunogenicity Testing Service Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Immunogenicity Testing Service Breakdown Data by Type
4.1 Global Immunogenicity Testing Service Historic Market Size by Type (2019-2024)
4.2 Global Immunogenicity Testing Service Forecasted Market Size by Type (2025-2030)
5 Immunogenicity Testing Service Breakdown Data by Application
5.1 Global Immunogenicity Testing Service Historic Market Size by Application (2019-2024)
5.2 Global Immunogenicity Testing Service Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Immunogenicity Testing Service Market Size (2019-2030)
6.2 North America Immunogenicity Testing Service Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Immunogenicity Testing Service Market Size by Country (2019-2024)
6.4 North America Immunogenicity Testing Service Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Immunogenicity Testing Service Market Size (2019-2030)
7.2 Europe Immunogenicity Testing Service Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Immunogenicity Testing Service Market Size by Country (2019-2024)
7.4 Europe Immunogenicity Testing Service Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Immunogenicity Testing Service Market Size (2019-2030)
8.2 Asia-Pacific Immunogenicity Testing Service Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Immunogenicity Testing Service Market Size by Region (2019-2024)
8.4 Asia-Pacific Immunogenicity Testing Service Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Immunogenicity Testing Service Market Size (2019-2030)
9.2 Latin America Immunogenicity Testing Service Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Immunogenicity Testing Service Market Size by Country (2019-2024)
9.4 Latin America Immunogenicity Testing Service Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Immunogenicity Testing Service Market Size (2019-2030)
10.2 Middle East & Africa Immunogenicity Testing Service Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Immunogenicity Testing Service Market Size by Country (2019-2024)
10.4 Middle East & Africa Immunogenicity Testing Service Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Profacgen
11.1.1 Profacgen Company Detail
11.1.2 Profacgen Business Overview
11.1.3 Profacgen Immunogenicity Testing Service Introduction
11.1.4 Profacgen Revenue in Immunogenicity Testing Service Business (2019-2024)
11.1.5 Profacgen Recent Development
11.2 Charles River Laboratories
11.2.1 Charles River Laboratories Company Detail
11.2.2 Charles River Laboratories Business Overview
11.2.3 Charles River Laboratories Immunogenicity Testing Service Introduction
11.2.4 Charles River Laboratories Revenue in Immunogenicity Testing Service Business (2019-2024)
11.2.5 Charles River Laboratories Recent Development
11.3 Pacific BioLabs
11.3.1 Pacific BioLabs Company Detail
11.3.2 Pacific BioLabs Business Overview
11.3.3 Pacific BioLabs Immunogenicity Testing Service Introduction
11.3.4 Pacific BioLabs Revenue in Immunogenicity Testing Service Business (2019-2024)
11.3.5 Pacific BioLabs Recent Development
11.4 Celerion
11.4.1 Celerion Company Detail
11.4.2 Celerion Business Overview
11.4.3 Celerion Immunogenicity Testing Service Introduction
11.4.4 Celerion Revenue in Immunogenicity Testing Service Business (2019-2024)
11.4.5 Celerion Recent Development
11.5 Precision Medicine Group
11.5.1 Precision Medicine Group Company Detail
11.5.2 Precision Medicine Group Business Overview
11.5.3 Precision Medicine Group Immunogenicity Testing Service Introduction
11.5.4 Precision Medicine Group Revenue in Immunogenicity Testing Service Business (2019-2024)
11.5.5 Precision Medicine Group Recent Development
11.6 BioAgilytix
11.6.1 BioAgilytix Company Detail
11.6.2 BioAgilytix Business Overview
11.6.3 BioAgilytix Immunogenicity Testing Service Introduction
11.6.4 BioAgilytix Revenue in Immunogenicity Testing Service Business (2019-2024)
11.6.5 BioAgilytix Recent Development
11.7 FyoniBio
11.7.1 FyoniBio Company Detail
11.7.2 FyoniBio Business Overview
11.7.3 FyoniBio Immunogenicity Testing Service Introduction
11.7.4 FyoniBio Revenue in Immunogenicity Testing Service Business (2019-2024)
11.7.5 FyoniBio Recent Development
11.8 Chimera Biotec
11.8.1 Chimera Biotec Company Detail
11.8.2 Chimera Biotec Business Overview
11.8.3 Chimera Biotec Immunogenicity Testing Service Introduction
11.8.4 Chimera Biotec Revenue in Immunogenicity Testing Service Business (2019-2024)
11.8.5 Chimera Biotec Recent Development
11.9 Alcyomics
11.9.1 Alcyomics Company Detail
11.9.2 Alcyomics Business Overview
11.9.3 Alcyomics Immunogenicity Testing Service Introduction
11.9.4 Alcyomics Revenue in Immunogenicity Testing Service Business (2019-2024)
11.9.5 Alcyomics Recent Development
11.10 ProImmune
11.10.1 ProImmune Company Detail
11.10.2 ProImmune Business Overview
11.10.3 ProImmune Immunogenicity Testing Service Introduction
11.10.4 ProImmune Revenue in Immunogenicity Testing Service Business (2019-2024)
11.10.5 ProImmune Recent Development
11.11 Creative Biolabs
11.11.1 Creative Biolabs Company Detail
11.11.2 Creative Biolabs Business Overview
11.11.3 Creative Biolabs Immunogenicity Testing Service Introduction
11.11.4 Creative Biolabs Revenue in Immunogenicity Testing Service Business (2019-2024)
11.11.5 Creative Biolabs Recent Development
11.12 SGS
11.12.1 SGS Company Detail
11.12.2 SGS Business Overview
11.12.3 SGS Immunogenicity Testing Service Introduction
11.12.4 SGS Revenue in Immunogenicity Testing Service Business (2019-2024)
11.12.5 SGS Recent Development
11.13 Eurofins Scientific
11.13.1 Eurofins Scientific Company Detail
11.13.2 Eurofins Scientific Business Overview
11.13.3 Eurofins Scientific Immunogenicity Testing Service Introduction
11.13.4 Eurofins Scientific Revenue in Immunogenicity Testing Service Business (2019-2024)
11.13.5 Eurofins Scientific Recent Development
11.14 Syrinx Bioanalytics
11.14.1 Syrinx Bioanalytics Company Detail
11.14.2 Syrinx Bioanalytics Business Overview
11.14.3 Syrinx Bioanalytics Immunogenicity Testing Service Introduction
11.14.4 Syrinx Bioanalytics Revenue in Immunogenicity Testing Service Business (2019-2024)
11.14.5 Syrinx Bioanalytics Recent Development
11.15 Pharmaron
11.15.1 Pharmaron Company Detail
11.15.2 Pharmaron Business Overview
11.15.3 Pharmaron Immunogenicity Testing Service Introduction
11.15.4 Pharmaron Revenue in Immunogenicity Testing Service Business (2019-2024)
11.15.5 Pharmaron Recent Development
11.16 NorthEast BioAnalytical Laboratories
11.16.1 NorthEast BioAnalytical Laboratories Company Detail
11.16.2 NorthEast BioAnalytical Laboratories Business Overview
11.16.3 NorthEast BioAnalytical Laboratories Immunogenicity Testing Service Introduction
11.16.4 NorthEast BioAnalytical Laboratories Revenue in Immunogenicity Testing Service Business (2019-2024)
11.16.5 NorthEast BioAnalytical Laboratories Recent Development
11.17 Svar Life Science
11.17.1 Svar Life Science Company Detail
11.17.2 Svar Life Science Business Overview
11.17.3 Svar Life Science Immunogenicity Testing Service Introduction
11.17.4 Svar Life Science Revenue in Immunogenicity Testing Service Business (2019-2024)
11.17.5 Svar Life Science Recent Development
11.18 CellCarta
11.18.1 CellCarta Company Detail
11.18.2 CellCarta Business Overview
11.18.3 CellCarta Immunogenicity Testing Service Introduction
11.18.4 CellCarta Revenue in Immunogenicity Testing Service Business (2019-2024)
11.18.5 CellCarta Recent Development
11.19 BioGenes
11.19.1 BioGenes Company Detail
11.19.2 BioGenes Business Overview
11.19.3 BioGenes Immunogenicity Testing Service Introduction
11.19.4 BioGenes Revenue in Immunogenicity Testing Service Business (2019-2024)
11.19.5 BioGenes Recent Development
11.20 EpiVax
11.20.1 EpiVax Company Detail
11.20.2 EpiVax Business Overview
11.20.3 EpiVax Immunogenicity Testing Service Introduction
11.20.4 EpiVax Revenue in Immunogenicity Testing Service Business (2019-2024)
11.20.5 EpiVax Recent Development
11.21 ImmunXperts
11.21.1 ImmunXperts Company Detail
11.21.2 ImmunXperts Business Overview
11.21.3 ImmunXperts Immunogenicity Testing Service Introduction
11.21.4 ImmunXperts Revenue in Immunogenicity Testing Service Business (2019-2024)
11.21.5 ImmunXperts Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

Companies Mentioned:

Profacgen
Charles River Laboratories
Pacific BioLabs
Celerion
Precision Medicine Group
BioAgilytix
FyoniBio
Chimera Biotec
Alcyomics
ProImmune
Creative Biolabs
SGS
Eurofins Scientific
Syrinx Bioanalytics
Pharmaron
NorthEast BioAnalytical Laboratories
Svar Life Science
CellCarta
BioGenes
EpiVax
ImmunXperts

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂